Hitoshi Arioka

Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

Masatoshi Kudo, Ann‐Lii Cheng, Joong‐Won Park et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 189 citations

Hepatology, Medicine, Transcatheter Arterial Chemoembolisation +9

Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells.

Minoru Fukuda, Kohei Nishio, Fumihiko Kanzawa et al. · PubMed · 1996 · 156 citations

Chemoprevention Strategy, Cancer Biology, Pharmaceutical Chemistry +16

A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma

Fumihiko Kanai, Haruhiko Yoshida, Ryosuke Tateishi et al. · Cancer Chemotherapy and Pharmacology · 2010 · 97 citations

Hepatology, Medicine, Pathology +7

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition

Tatsunori Shimoi, Shigenori E. Nagai, Tetsuhiro Yoshinami et al. · Breast Cancer · 2020 · 75 citations · Full text

γ-Glutamylcysteine Synthetase Gene Overexpression Results in Increased Activity of the ATP-Dependent Glutathione S-Conjugate Export Pump and Cisplatin Resistance

H Kurokawa, Tomohisa Ishida, Kazuto Nishio et al. · Biochemical and Biophysical Research Communications · 1995 · 71 citations

Biosynthesis, Biochemistry, Natural Sciences +8